Sonova Holding (OTCMKTS:SONVY - Get Free Report)'s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $51.26 and traded as low as $47.03. Sonova shares last traded at $47.08, with a volume of 30,518 shares changing hands.
Wall Street Analysts Forecast Growth
A number of research firms have commented on SONVY. Jefferies Financial Group downgraded Sonova from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, March 18th. BNP Paribas Exane upgraded Sonova from a "strong sell" rating to a "strong-buy" rating in a research report on Tuesday, March 10th. Finally, Zacks Research raised Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, February 9th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".
Get Our Latest Stock Analysis on SONVY
Sonova Price Performance
The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24. The stock's 50 day moving average price is $48.02 and its two-hundred day moving average price is $51.26.
Sonova Company Profile
(
Get Free Report)
Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.